60 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
. Reimbursement policies fall far short of sustaining the R&D investment needed to produce the innovation that modern society demands. Developing … multinational pharma company operating in the country. The number of new launches, combined with rapid patient access through national reimbursement
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
related to donations made to charitable organizations which provide funding to patients who are pursuing claims for reimbursement from the
- 14
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
systems built on a fee- for-service model are facing significant financial and resource strain, and the restrictive drug pricing and reimbursement policies … reimbursement Delivering life-transforming treatments and vaccines requires more than developing medical breakthrough treatments and ensuring a safe
S-8
TAK
Takeda Pharmaceutical Co
28 Jun 23
Registration of securities for employees
6:35am
reimbursement therefor and interest thereon after the date of payment from such company;
(3) If a director of a company has assumed an obligation necessary
6-K
EX-99.1
io7y4duwr2o4ehhz fkf
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
2e4bp 9jph5d8m
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
ld36ss7ag
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
m8npqn2t 372
30 May 23
Current report (foreign)
6:11am
6-K
paukyk35 3e55j9o6
11 May 23
Current report (foreign)
6:07am
S-8
h2svax9
29 Jun 22
Registration of securities for employees
6:13am
6-K
EX-99.1
15wnreuss lhby
31 May 22
Current report (foreign)
12:00am
6-K
wrrzzb9
11 Jan 22
Current report (foreign)
6:04am
6-K
EX-99.1
6gv6k ft5m2
11 Jan 22
Current report (foreign)
6:02am
S-8
65hy dllbk
28 Oct 21
Registration of securities for employees
6:33am
6-K
EX-99.1
26x8 9you8xr
29 Jun 21
Current report (foreign)
7:38am